There are no products listed under this category.
DGKK
DGKK (diacylglycerol kinase kappa) is a membrane-associated lipid kinase that converts diacylglycerol (DAG) into phosphatidic acid (PA). By setting the balance between these two bioactive lipids, the DGKK enzyme sits at a switch point between distinct second-messenger signalling pathways. Browse Assay Genie's current range of DGKK research reagents below, or read on for the biology behind the target.
DGKK is a diacylglycerol kinase that phosphorylates diacylglycerol (DAG), producing phosphatidic acid (PA, also called phosphatidate). In doing so it regulates the relative levels of two bioactive lipids. DAG and PA act as second messengers with different cellular targets and opposite effects in many biological processes, so diacylglycerol kinase activity works as a central switch between the signalling pathways that each lipid activates.
The DGKK gene encodes a protein that belongs to the eukaryotic diacylglycerol kinase family, and HGNC places it in the diacylglycerol kinase family gene group. The enzyme carries the EC number 2.7.1.107 and is annotated as a membrane protein, with UniProt listing the cell membrane as its subcellular location. According to the NCBI Gene summary, the encoded enzyme is inhibited by hydrogen peroxide.
On the disease side, variations in the DGKK gene have been associated with hypospadias, according to the RefSeq summary. This makes DGKK a point of interest for researchers studying lipid signalling and genetic contributions to this condition. As a member of a family that controls DAG and PA balance, DGKK is also a useful reference for work comparing the roles of individual diacylglycerol kinases. Researchers working on a DGKK antibody, DGKK ELISA kit or recombinant DGKK protein can use the information on this page as biological background for experimental design.
DGKK converts DAG to PA, so it is relevant to studies of how the balance of these two lipids shapes signalling outputs.
Variations in the DGKK gene have been associated with hypospadias, making it a candidate for genetic and developmental research.
As a member of the eukaryotic diacylglycerol kinase family, DGKK supports comparative work on how family members regulate DAG and PA levels.
DGKK is a cell membrane enzyme inhibited by hydrogen peroxide, which is relevant to research on redox control of lipid kinase activity.
DGKK is a diacylglycerol kinase that phosphorylates diacylglycerol to form phosphatidic acid. This regulates the levels of both lipids, which act as second messengers with different cellular targets and opposite effects, so the enzyme works as a central switch between their signalling pathways.
The approved HGNC name is diacylglycerol kinase kappa, and the symbol is DGKK. No alternative symbols or previous names are listed in the sources used here. UniProt uses the same protein name, and the enzyme has the EC number 2.7.1.107.
The NCBI Gene summary, provided by RefSeq, states that variations in the DGKK gene have been associated with hypospadias. The same summary notes that the encoded membrane enzyme is inhibited by hydrogen peroxide. Check the datasheet of any product for its validated reactivity.
Other diacylglycerol kinase family members and lipid-signalling enzymes with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q5KSL6; product specifications from Assay Genie datasheets.
There are no products listed under this category.